女性 の 心血管 リスク の 評価 に 関する 性別 特定 の 要因 の 使用
Circulation
|February 18, 2020
まとめ
心血管疾患 (CVD) は女性にとって大きな健康問題です. 女性に特有のリスク要因を認識することは,女性のCVDの適切な診断,予防,治療に不可欠です.
科学分野:
- 心臓病科
- 女性 の 健康
- 予防 医療
背景:
- 心血管疾患 (CVD) は米国で女性の死亡の主な原因です.
- 女性は男性と比べて 適切な診断や予防ケアや 積極的な治療を受けることが少なくなります
- 性差は女性特有のCVDリスク要因とマーカーを明らかにした.
研究 の 目的:
- 性別特有の女性における 心血管疾患の危険因子を強調する.
- 心血管リスク評価における産婦人科病歴の重要性を強調する.
- 女性特有の危険因子に基づく予防措置を開始するための枠組みを提供すること.
主な方法:
- 女性におけるCVD予防に関する現在のガイドライン (2018 AHA/ACC,2019 ACC/AHA) のレビュー.
- 性別特有のCVDの危険因子とリスクを高める因子の特定と議論
- 婦人科と産科の履歴を心臓血管リスク評価に組み込むことに重点を置く
主要な成果:
- ガイドラインには,女性特有のリスク増強因子が含まれており, 動脈硬化性CVDのリスクが増加していることが示されています.
- これらの要因は,生活習慣への介入と スタチンの治療を 強化することを示唆しています.
- リスク評価には,女性特有の病歴を含む包括的なアプローチが不可欠です.
結論:
- 性別特有の危険因子に対処することは,女性における心血管疾患の改善に不可欠です.
- 婦人科と産婦人科の履歴を統合することで,心血管リスク評価の精度を高めることができます.
- 性別によって特定されたCVDリスクのある女性には,積極的で強化された予防戦略が必要である.
さらに関連する動画
07:51Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
7.9K
06:18An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
12.7K
関連する概念動画
01:23Assessment of the Cardiovascular System I: Subjective Data
706
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
706
01:30Coronary Artery Disease I: Introduction
797
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
797
01:29Assessment of the Cardiovascular System II: Inspection
730
Inspection is the initial step in assessing the cardiovascular system. It involves a detailed visual examination that provides crucial information about a patient's circulatory and cardiac health. This systematic process, conducted from head to toe, helps identify signs of cardiovascular conditions by observing physical appearance, skin and mucous membranes, jugular and carotid pulsations, chest symmetry, and the condition of the extremities.
Head and Neck
Head and Neck
730
01:30Factors Influencing Heart Rate
6.0K
The heart rate, or pulse rate, is a vital indicator of cardiovascular health. It reflects the number of times the heart beats per minute. Various physiological and environmental factors influence heart rate, increasing or decreasing cardiac output. Understanding these factors is crucial for assessing heart function and identifying potential health issues.
Let us explore the significant factors affecting heart rate, including age, body temperature, posture, acute pain, chemical influences,...
Let us explore the significant factors affecting heart rate, including age, body temperature, posture, acute pain, chemical influences,...
6.0K
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
473
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
473
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
709
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
709